CIK 0000897448 · Accelerated filer
AMARIN CORP PLCUK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 353 1 6699 020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-10-30 | Berg Aaron CHIEF COMMERCIAL OFFICER | Option exercise | +1,528 | 214,470 | ||
| 2020-10-30 | Berg Aaron CHIEF COMMERCIAL OFFICER | Option exercise | +1,528 | 215,998 | ||
| 2020-10-30 | Berg Aaron CHIEF COMMERCIAL OFFICER | Shares withheld for taxes | −1,506 | $4.86 | $7K | 214,492 |
| 2020-10-30 | Berg Aaron CHIEF COMMERCIAL OFFICER | Option exercise · Restricted Stock Units | −1,528 | 15,277 | ||
| 2020-10-30 | Berg Aaron CHIEF COMMERCIAL OFFICER | Option exercise · Restricted Stock Units | −1,528 | 15,277 | ||
| 2020-10-30 | Kalb Michael Wayne SVP and CFO | Option exercise | +1,528 | 98,441 | ||
| 2020-10-30 | Kalb Michael Wayne SVP and CFO | Option exercise | +1,528 | 99,969 | ||
| 2020-10-30 | Kalb Michael Wayne SVP and CFO | Shares withheld for taxes | −1,498 | $4.86 | $7K | 98,471 |
| 2020-10-30 | Kalb Michael Wayne SVP and CFO | Option exercise · Restricted Stock Units | −1,528 | 15,277 | ||
| 2020-10-30 | Kalb Michael Wayne SVP and CFO | Option exercise · Restricted Stock Units | −1,528 | 15,277 | ||
| 2020-10-30 | Ketchum Steven B Chief Scientific Officer | Option exercise | +1,528 | 528,382 | ||
| 2020-10-30 | Ketchum Steven B Chief Scientific Officer | Option exercise | +1,528 | 529,910 | ||
| 2020-10-30 | Ketchum Steven B Chief Scientific Officer | Shares withheld for taxes | −1,506 | $4.86 | $7K | 528,404 |
| 2020-10-30 | Ketchum Steven B Chief Scientific Officer | Option exercise · Restricted Stock Units | −1,528 | 15,277 | ||
| 2020-10-30 | Ketchum Steven B Chief Scientific Officer | Option exercise · Restricted Stock Units | −1,528 | 15,277 | ||
| 2020-10-30 | Kennedy Joseph T General Counsel | Option exercise | +1,806 | 211,075 | ||
| 2020-10-30 | Kennedy Joseph T General Counsel | Option exercise | +1,806 | 212,881 | ||
| 2020-10-30 | Kennedy Joseph T General Counsel | Shares withheld for taxes | −1,902 | $4.86 | $9K | 210,979 |
| 2020-10-30 | Kennedy Joseph T General Counsel | Option exercise · Restricted Stock Units | −1,806 | 18,054 | ||
| 2020-10-30 | Kennedy Joseph T General Counsel | Option exercise · Restricted Stock Units | −1,806 | 18,054 |
Page 44 of 67 · 1,339 trades